Development of Photoonycholysis with Vandetanib Therapy

Vandetanib therapy is a novel once-daily oral multitargeted tyrosine kinase inhibitor, which is currently used in advanced or metastatic medullary thyroid cancer. Skin toxicities are among the most prevalent adverse events reported with this targeted therapy (e.g. acne-like rash, hand-foot skin reac...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Skin Appendage Disord
Main Authors: Negulescu, Miruna, Zerdoud, Slimane, Boulinguez, Serge, Tournier, Emilie, Delord, Jean-Pierre, Baran, Robert, Sibaud, Vincent
Format: Artigo
Sprog:Inglês
Udgivet: S. Karger AG 2017
Fag:
Novel Insights from Clinical Practice
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5264363/
https://ncbi.nlm.nih.gov/pubmed/28232923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000452425
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker